Mianserin Hydrochloride

盐酸米安色林

Report date: 2025/07/03 16:33:25
NME

Base Information

Drug NameMianserin Hydrochloride
Drug Alias NamemianserinMianserineMianserynaMianserinaMianserinum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor inverse agonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsSedationDepressive DisorderAnesthesia
Global Approved IndicationsSedationDepressive DisorderAnesthesia
Approved Indications in ChinaDepressive Disorder
Original Approved Country/TerritoryJapan
Original Approved Date1983/04/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp NvorganonDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Corp NvorganonDaiichi Sankyo Co LtdTianjin Remedy Research Institute +[4] 
Inactive CompaniesN/A
Active IndicationsSedationDepressive DisorderAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A